(1)
The Role of Oxybutynin Chloride in the Management of Patientswith Benign Prostatic Hyperplasia. Tikrit J. Pharm. Sci. 2023, 4 (1), 63-68. https://doi.org/10.25130/tjphs.2008.4.8.63.68.